CD8A and head and neck squamous cell carcinoma: It appeared that combination of amivantamab and pembrolizumab significantly enhanced infiltration of granzyme B–producing CD8 T cells was in the TME of HNSCC PDX (P < 0.01) and enhanced neoantigen-associated central memory CD8 T cells in circulating immune cells.